Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers [Phase 4]
Phase 4 clinical trial assessing the effect of anti-inflammatory treatment on insulin resistance in healthy volunteers; results have been po…
-
CLINICAL_TRIALS withdrawal · 2013-03-05Clinical Trial Update: Proteus Sustained Behavior Change Study [NA]
Proteus Digital Health-sponsored trial evaluating sustained behavior change for Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes [NA]
An update on a completed clinical trial evaluating the effects of omega-3 polyunsaturated fatty acids on chylomicron secretion and the expre…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes [Phase 3]
A Phase 3 trial update evaluating acarbose's effect on endothelial function after a mixed meal in adults newly diagnosed with type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism [NA]
A completed Zhejiang University–sponsored clinical trial assessing whether diacylglycerol oil influences risk factors for Type 2 diabetes me…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: The Effect of DBcare, a Food Supplement on Diabetes Control [NA]
A completed clinical trial update evaluating the effects of DBcare, a food supplement, on diabetes control.
-
FDA approval · 2013-02-27FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy [Phase 3]
It reviews a Phase 3 trial comparing Insuman Comb 25 to Novolin 30R given twice daily for 24 weeks in Type 2 diabetes patients on insulin th…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle [Phase 4]
Phase 4 study evaluating Actos (pioglitazone) effects on glucose transporters in muscle in type 2 diabetes; the trial has completed.
-
FDA approval · 2013-02-25FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Acetyl-L-Carnitine in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating acetyl-L-carnitine in patients with type 2 diabetes mellitus, including hypertension, has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes [NA]
A completed clinical trial evaluated the effect of an automated telephone intervention on HbA1c levels in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk [Phase 2]
Phase 2 clinical trial evaluating calorie restriction to prevent renal abnormalities in adults with abdominal obesity and type 2 diabetes; t…
-
FDA approval · 2013-02-21FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: INSUlin Regimens and VASCular Functions [NA]
This ClinicalTrials.gov update notes the completion of a study investigating insulin regimens and vascular function in people with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India
A completed AstraZeneca-sponsored clinical trial update evaluating the management of dyslipidemia in adults with type 2 diabetes mellitus in…
-
CLINICAL_TRIALS research · 2013-02-20Clinical Trial Update: Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel
This clinical trial investigates predictors of developing Type 2 diabetes mellitus among the Circassian minority in Israel; the current stat…
-
FDA approval · 2013-02-15FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) by Cosette Pharmaceuticals, Inc., updating its labeling …
-
FDA label_change · 2013-02-15FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by sanofi-aventis U.S. LLC, resulting in a labeling update …
-
FDA approval · 2013-02-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-02-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients [Phase 3]
A Phase 3 trial update reporting completion of a study evaluating CJ-30001 and CJ-30002 in patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin [Phase 3]
This Phase 3 clinical trial update compares CKD-501 against pioglitazone when added to metformin in patients with Type 2 Diabetes Mellitus, …
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease [NA]
A clinical trial update examining the effects of paricalcitol (Zemplar) on endothelial function and inflammation in people with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Single Ascending Dose Trial in Patients With Type 2 Diabetes [Phase 1]
A single ascending dose Phase 1 trial in patients with Type 2 diabetes mellitus sponsored by Amgen was terminated.